SV Health Investors
在场
SV Health Investors 在 2 个国家有直接业务。
高管
查看带有其 30 名主要高管的组织结构图
SV Health Investors 搜索最多的简介
- Eugene Hill, Chairman of the Board
- Mike Ross, Managing Partner, Biotechnology
- Brent Faduski, Chief Financial Officer, Chief Compliance Officer a...
高管在SV Health Investors变化
- Nikola Trbovic 曾任 Partner, Biotechnology, 现升职为 Managing Partner, Biotechnology (新闻发布的2024一月8号).
- Jamil Beg已作为Partner, Biotechnology加入公司 (新闻发布的2024一月8号).
创建提醒
跟踪 SV Health Investors 的高管变动
基金
SV Health Investors 拥有 1,474 家竞争者，其中包括 Lloyds Development Capital (联合王国)、BlackRock (美国(美洲)) 和 WindRose Health Investors (美国(美洲))。
Popular M&A news in 基金
- Abrdn Private Equity Opportunities Trust将改名为Patria Capital Partners。 (公布2024四月30号).
- HMC Capital 已收购 StratCap (公布2024二月28号).
- Thomvest Ventures 刚刚宣布为 250 筹款数百万美元。 (公布2024一月17号).
基金 行业的其他推荐联系人
- Valor Equity Partners 企业 Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer
- Vanguard 企业 Mortimer Buckley - Chairman of the Board and Chief Executive Officer (retiring in Dec 2024)
- Caisse de Dépôt et Placement du Québec 企业 Jean-Marc Arbaud - President and Chief Executive Officer of CDPQ Infra
消息
SV Health Investors 的最新新闻稿
- Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline - SV Health Investors
- Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair - SV Health Investors
- Former SV Portfolio Company Deciphera acquired by Ono Pharmaceutical for $2.4B after biotech's Phase 3 win - SV Health Investors
- SV Biotech launches its inaugural ESG and Impact Report - SV Health Investors
- Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia - SV Health Investors
- UK dementia adviser [Ruth McKernan] wants half a million volunteers for clinical trials - SV Health Investors
- Dementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia - SV Health Investors
- Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference - SV Health Investors
- Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease - SV Health Investors
- Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia - SV Health Investors
- View more press releases Close
通过电子邮件
